Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
2006 1
2008 2
2009 2
2010 3
2011 2
2012 4
2013 3
2014 7
2015 4
2016 4
2017 5
2018 7
2019 8
2020 13
2021 11
2022 8
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis.
Maz M, Chung SA, Abril A, Langford CA, Gorelik M, Guyatt G, Archer AM, Conn DL, Full KA, Grayson PC, Ibarra MF, Imundo LF, Kim S, Merkel PA, Rhee RL, Seo P, Stone JH, Sule S, Sundel RP, Vitobaldi OI, Warner A, Byram K, Dua AB, Husainat N, James KE, Kalot MA, Lin YC, Springer JM, Turgunbaev M, Villa-Forte A, Turner AS, Mustafa RA. Maz M, et al. Arthritis Rheumatol. 2021 Aug;73(8):1349-1365. doi: 10.1002/art.41774. Epub 2021 Jul 8. Arthritis Rheumatol. 2021. PMID: 34235884
OBJECTIVE: To provide evidence-based recommendations and expert guidance for the management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large vessel vasculitis. METHODS: Clinical questions regarding diagnostic testing, treatment …
OBJECTIVE: To provide evidence-based recommendations and expert guidance for the management of giant cell arteritis (GCA) and Takayasu arter …
2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E, Cassie R, Cid MC, Dasgupta B, Dejaco C, Hatemi G, Hollinger N, Mahr A, Mollan SP, Mukhtyar C, Ponte C, Salvarani C, Sivakumar R, Tian X, Tomasson G, Turesson C, Schmidt W, Villiger PM, Watts R, Young C, Luqmani RA. Hellmich B, et al. Ann Rheum Dis. 2020 Jan;79(1):19-30. doi: 10.1136/annrheumdis-2019-215672. Epub 2019 Jul 3. Ann Rheum Dis. 2020. PMID: 31270110
BACKGROUND: Since the publication of the European League Against Rheumatism (EULAR) recommendations for the management of large vessel vasculitis (LVV) in 2009, several relevant randomised clinical trials and cohort analyses have been published, which have th …
BACKGROUND: Since the publication of the European League Against Rheumatism (EULAR) recommendations for the management of large ve …
Updates in the diagnosis and management of Takayasu's arteritis.
Somashekar A, Leung YT. Somashekar A, et al. Postgrad Med. 2023 Jan;135(sup1):14-21. doi: 10.1080/00325481.2022.2159723. Epub 2023 Jan 2. Postgrad Med. 2023. PMID: 36588528 Review.
Takayasu's arteritis is a rare, chronic, large vessel vasculitis which affects the aorta and its large branches. ...
Takayasu's arteritis is a rare, chronic, large vessel vasculitis which affects the aorta and its large branches. …
2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis.
Grayson PC, Ponte C, Suppiah R, Robson JC, Gribbons KB, Judge A, Craven A, Khalid S, Hutchings A, Danda D, Luqmani RA, Watts RA, Merkel PA; DCVAS Study Group. Grayson PC, et al. Ann Rheum Dis. 2022 Dec;81(12):1654-1660. doi: 10.1136/ard-2022-223482. Epub 2022 Nov 9. Ann Rheum Dis. 2022. PMID: 36351705
OBJECTIVE: To develop and validate new classification criteria for Takayasu arteritis (TAK). METHODS: Patients with vasculitis or comparator diseases were recruited into an international cohort. ...The validation data set consisted of an additional 146 cases of TAK and 127 …
OBJECTIVE: To develop and validate new classification criteria for Takayasu arteritis (TAK). METHODS: Patients with vasculitis or com …
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update.
Dejaco C, Ramiro S, Bond M, Bosch P, Ponte C, Mackie SL, Bley TA, Blockmans D, Brolin S, Bolek EC, Cassie R, Cid MC, Molina-Collada J, Dasgupta B, Nielsen BD, De Miguel E, Direskeneli H, Duftner C, Hočevar A, Molto A, Schäfer VS, Seitz L, Slart RHJA, Schmidt WA. Dejaco C, et al. Ann Rheum Dis. 2024 May 15;83(6):741-751. doi: 10.1136/ard-2023-224543. Ann Rheum Dis. 2024. PMID: 37550004
OBJECTIVES: To update the EULAR recommendations for the use of imaging modalities in primary large vessel vasculitis (LVV). METHODS: A systematic literature review update was performed to retrieve new evidence on ultrasound, MRI, CT and [(18)F]-fluorodeoxyglu …
OBJECTIVES: To update the EULAR recommendations for the use of imaging modalities in primary large vessel vasculitis (L …
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome.
Drosos GC, Vedder D, Houben E, Boekel L, Atzeni F, Badreh S, Boumpas DT, Brodin N, Bruce IN, González-Gay MÁ, Jacobsen S, Kerekes G, Marchiori F, Mukhtyar C, Ramos-Casals M, Sattar N, Schreiber K, Sciascia S, Svenungsson E, Szekanecz Z, Tausche AK, Tyndall A, van Halm V, Voskuyl A, Macfarlane GJ, Ward MM, Nurmohamed MT, Tektonidou MG. Drosos GC, et al. Ann Rheum Dis. 2022 Jun;81(6):768-779. doi: 10.1136/annrheumdis-2021-221733. Epub 2022 Feb 2. Ann Rheum Dis. 2022. PMID: 35110331
Lipid management should follow general population guidelines, and antiplatelet use in SLE, APS and large-vessel vasculitis should follow prior EULAR recommendations. A serum uric acid level <0.36 mmol/L (<6 mg/dL) in gout, and disease activity control a …
Lipid management should follow general population guidelines, and antiplatelet use in SLE, APS and large-vessel vasculitis …
Management of large-vessel vasculitis.
Salvarani C, Hatemi G. Salvarani C, et al. Curr Opin Rheumatol. 2019 Jan;31(1):25-31. doi: 10.1097/BOR.0000000000000561. Curr Opin Rheumatol. 2019. PMID: 30461542 Review.
PURPOSE OF REVIEW: Glucocorticoids are the mainstay of therapy for large-vessel vasculitis, but potential toxicity and frequent relapses led to studies with nonbiologic and biologic glucocorticoid-sparing agents. ...SUMMARY: Despite recent randomized c …
PURPOSE OF REVIEW: Glucocorticoids are the mainstay of therapy for large-vessel vasculitis, but potential toxici …
Isolated Aortitis: Workup and Management.
Kermani TA, Byram K. Kermani TA, et al. Rheum Dis Clin North Am. 2023 Aug;49(3):523-543. doi: 10.1016/j.rdc.2023.03.013. Epub 2023 Apr 28. Rheum Dis Clin North Am. 2023. PMID: 37331731 Review.
The finding of aortitis, often incidentally noted on surgical resection, should prompt evaluation for secondary causes including large-vessel vasculitis. In a large proportion of cases, no other inflammatory cause is identified and the diagnosis of cli …
The finding of aortitis, often incidentally noted on surgical resection, should prompt evaluation for secondary causes including large …
Current Diagnosis and Management of Takayasu Arteritis.
As C, Danda D. As C, et al. Int Heart J. 2023;64(4):519-534. doi: 10.1536/ihj.23-195. Int Heart J. 2023. PMID: 37518335 Free article.
Takayasu arteritis (TA or TAK) is a chronic large vessel vasculitis with predilection to affect the aorta and its branches. ...
Takayasu arteritis (TA or TAK) is a chronic large vessel vasculitis with predilection to affect the aorta and its branc …
Comparing treatment options for large vessel vasculitis.
Macaluso F, Marvisi C, Castrignanò P, Pipitone N, Salvarani C. Macaluso F, et al. Expert Rev Clin Immunol. 2022 Aug;18(8):793-805. doi: 10.1080/1744666X.2022.2092098. Epub 2022 Jun 29. Expert Rev Clin Immunol. 2022. PMID: 35714219 Review.
INTRODUCTION: Giant cell arteritis (GCA) and Takayasu arteritis (TAK) are the major forms of large vessel vasculitis (LVV). Glucocorticoids represent the cornerstone of LVV treatment, however, relapses and recurrences frequently occur when they are tapered or …
INTRODUCTION: Giant cell arteritis (GCA) and Takayasu arteritis (TAK) are the major forms of large vessel vasculitis (L …
89 results